Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.320
+0.050 (1.53%)
At close: May 8, 2026, 4:00 PM EDT
3.300
-0.020 (-0.61%)
After-hours: May 8, 2026, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.76 billion as of May 8, 2026. Its market cap has decreased by -23.82% in one year.
Market Cap
1.76B
Enterprise Value
1.18B
1-Year Change
-23.82%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.76B, a decrease of -65.28%. That is a compound annual growth rate of -18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.76B | -17.22% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galapagos NV | 1.91B |
| Harmony Biosciences Holdings | 1.90B |
| Vericel | 1.87B |
| Palvella Therapeutics | 1.86B |
| Syndax Pharmaceuticals | 1.83B |
| Viridian Therapeutics | 1.81B |
| Rapport Therapeutics | 1.77B |
| Nuvation Bio | 1.75B |